New Delhi: Ahmedabad-based drug maker Zydus Cadila is aiming to clock $3 billion sales by 2015, while it expects to cross the $1 billion mark by 2010.
In a presentation made to investors, the company said it “shall be a leading global healthcare provider with robust product pipeline and sales of over $1 billion by 2010. We shall achieve sales of $3 billion by 2015 and be a research -based pharmaceutical company by 2020.”
While it did not specify how it will become a $3 billion firm by 2015, the company is looking at its overseas sales to contribute 45% to its overall sales by 2010, compared with 37% in 2007-08.
Exports contributed around $217 million to its over- all revenue in 2007-08 fiscal, which the company expects to increase to $450 million in 2010-11 fiscal, a growth of over 100%.
Of the projected $450 million from exports, Zydus cadila expects $250 million from sales of formulations to developed countries and $80 million from emerging markets.
Besides this, the company plans to file around 12-15 abbreviated new drug applications (ANDAs) every year and it also plans to launch 8-10 products every year as part of its plans to achieve the 2015 target.
The company has clocked a revenue of Rs2,325 crore in 2007-08 fiscal.